These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6848356)

  • 21. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between estrogen receptor and subcellular structures of target cells: nuclear localization of unoccupied receptor and its modification induced by estradiol.
    Puca GA; Medici N; Armetta I; Nigro V; Moncharmont B; Molinari AM
    Ann N Y Acad Sci; 1986; 464():168-89. PubMed ID: 3524348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What differentiates antiestrogen-liganded vs estradiol-liganded estrogen receptor action?
    Klinge CM; Bambara RA; Hilf R
    Oncol Res; 1992; 4(4-5):137-44. PubMed ID: 1504373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular distribution and gene regulation of estrogen receptors alpha and beta in the rat pituitary gland.
    Mitchner NA; Garlick C; Ben-Jonathan N
    Endocrinology; 1998 Sep; 139(9):3976-83. PubMed ID: 9724053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific binding of estrogen and estrogen-receptor complex by microsomes from estrogen-responsive tissues of the rat.
    Watson GH; Muldoon TG
    Endocrinology; 1985 Oct; 117(4):1341-9. PubMed ID: 4029080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
    Ruh MF; Singh RK; Mak P; Callard GV
    Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
    Katzenellenbogen BS; Ferguson ER
    Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of estrogen and antiestrogen on plasma renin substrate levels and hepatic estrogen receptors in the rat.
    Kneifel MA; Katzenellenbogen BS
    Endocrinology; 1981 Feb; 108(2):545-52. PubMed ID: 7004858
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigation of hormone-receptor interactions by means of fluorescence labeling.
    Dandliker WB; Brawn RJ; Hsu ML; Brawn PN; Levin J; Meyers CY; Kolb VM
    Cancer Res; 1978 Nov; 38(11 Pt 2):4212-24. PubMed ID: 212190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
    Sheen YY; Simpson DM; Katzenellenbogen BS
    Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
    Kraus WL; Katzenellenbogen BS
    Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue distribution of the radiolabeled antiestrogen [125I]iodotamoxifen.
    Hanson RN; Seitz DE
    Int J Nucl Med Biol; 1982; 9(2):105-7. PubMed ID: 7107123
    [No Abstract]   [Full Text] [Related]  

  • 34. Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
    Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Nov; 30(11):968-71. PubMed ID: 1293041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
    Rorke EA; Katzenellenbogen BS
    Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrogen receptor in rat thymus cytosol.
    Imanishi Y; Haruki Y; Seiki K
    Tokai J Exp Clin Med; 1980 Jul; 5(3):263-7. PubMed ID: 7222118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The occurrence of estrogen and progestin receptors and anti-estrogen binding sites (AEBS) in canine non-Hodgkin's lymphomas.
    Teske E; Besselink CM; Blankenstein MA; Rutteman GR; Misdorp W
    Anticancer Res; 1987; 7(4B):857-60. PubMed ID: 3674774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potent specific pure antiestrogen with clinical potential.
    Wakeling AE; Dukes M; Bowler J
    Cancer Res; 1991 Aug; 51(15):3867-73. PubMed ID: 1855205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal antiestrogens: their biological effects and potential mechanisms of action.
    Jordan VC; Dix CJ; Naylor KE; Prestwich G; Rowsby L
    J Toxicol Environ Health; 1978; 4(2-3):363-90. PubMed ID: 207880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.